genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Ironwood Pharmaceuticals
Industry News
Ironwood Licenses U.S. Rights to Zurampic from AstraZeneca
GEN Staff Writer
-
April 26, 2016
0
Industry News
Ironwood Halts Development of IW-9179 for Gastroparesis after Trial Failure
GEN Staff Writer
-
April 5, 2016
0
Insights
People in the News
GEN Staff Writer
-
April 15, 2013
0
Insights
People in the News
GEN Staff Writer
-
April 1, 2013
0
Insights
People in the News
GEN Staff Writer
-
March 15, 2013
0
Drug Discovery
Ironwood Pays Bionomics $3M to Co-Develop Its Anti-Anxiety Treatments
GEN Staff Writer
-
January 5, 2012
0
Drug Discovery
Ironwood Negotiates Access to Depomed’s Upper GI Drug Delivery Technology
GEN Staff Writer
-
July 28, 2011
0
News
Ironwood Taps Protagonist Technology for Peptide Therapeutic Development
GEN Staff Writer
-
January 19, 2011
0
News
New Phase III Data Confirms Linaclotide Eases the Pain and Burden of IBS-C
GEN Staff Writer
-
November 2, 2010
0
News
Ironwood Plans Mid-2011 NDA Filing for IBS Drug Following Positive Phase III Data
GEN Staff Writer
-
September 14, 2010
0
1
2
Page 1 of 2
Scroll Up
Scroll Up
